Lactose Monohydrate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB04465 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | esophageal varices with bleeding | KG + DL |
| 2 | esophageal varices without bleeding | KG + DL |
| 3 | varicose disease | KG + DL |
| 4 | Steel syndrome | KG + DL |
| 5 | cystinosis | KG + DL |
| 6 | growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant | KG + DL |
| 7 | mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies | KG + DL |
| 8 | Immunoerythromyeloid hypoplasia | KG + DL |
| 9 | familial apolipoprotein C-II deficiency | KG + DL |
| 10 | hypophosphatasia | KG + DL |
| 11 | inborn disorder of lysosomal amino acid transport | KG + DL |
| 12 | proximal myopathy with extrapyramidal signs | KG + DL |
| 13 | exocrine pancreatic insufficiency | KG + DL |
| 14 | free sialic acid storage disease | KG + DL |
| 15 | reticular dysgenesis | KG + DL |
| 16 | lung fibrosis-immunodeficiency-46,XX gonadal dysgenesis syndrome | KG + DL |
| 17 | diarrhea-vomiting due to trehalase deficiency | KG + DL |
| 18 | alpha-mannosidosis | KG + DL |
| 19 | oligosaccharidosis | KG + DL |
| 20 | cholesterol metabolism disease | KG + DL |
| 21 | ptosis-strabismus-ectopic pupils syndrome | KG + DL |
| 22 | T-B+ severe combined immunodeficiency due to gamma chain deficiency | KG + DL |
| 23 | ocular cystinosis | KG + DL |
| 24 | jaw-winking syndrome | KG + DL |
| 25 | congenital Horner syndrome (disease) | KG + DL |
| 26 | non-severe combined immunodeficiency | KG + DL |
| 27 | ptosis-vocal cord paralysis syndrome | KG + DL |
| 28 | camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye | KG + DL |
| 29 | skeletal muscle disease | KG + DL |
| 30 | ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome | KG + DL |
| 31 | glycogen storage disease due to GLUT2 deficiency | KG + DL |
| 32 | nephropathic cystinosis | KG + DL |
| 33 | intestinal disease due to vitamin absorption anomaly | KG + DL |
| 34 | Tay-Sachs disease | KG + DL |
| 35 | congenital entropion | KG + DL |
| 36 | pigmented paravenous retinochoroidal atrophy | KG + DL |
| 37 | Charcot-Marie-Tooth disease | KG + DL |
| 38 | congenital ectropion | KG + DL |
| 39 | mucopolysaccharidosis | KG + DL |
| 40 | inclusion myopathy | KG + DL |
| 41 | T-B+ severe combined immunodeficiency due to CD45 deficiency | KG + DL |
| 42 | lipase deficiency, combined | KG + DL |
| 43 | collagenous sprue | KG + DL |
| 44 | epiblepharon | KG + DL |
| 45 | chronic diarrhea with villous atrophy | KG + DL |
| 46 | combined immunodeficiency, X-linked | KG + DL |
| 47 | blind loop syndrome | KG + DL |
| 48 | tropical sprue | KG + DL |
| 49 | helicoid peripapillary chorioretinal degeneration | KG + DL |
| 50 | cone dystrophy | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.